-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. -
The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial InfarctionMaznyczka AM, Oldroyd KG, Berry C et al.
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS.
-
Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and KidneysParé G, Bhatt DL.
-
Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly PatientsShavadia JS, Holmes DN, Thomas L et al.
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin IY Sandoval, R Nowak, CR deFilippi et al.
-
Healed Culprit Plaques in Patients With Acute Coronary SyndromesFracassi F, Crea F, Jang IK et al.
-
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE TrialHenriques JP, Hoebers LP, EXPLORE Trial Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
